A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.
作者信息
Jiang Zefei, Ouyang Quchang, Sun Tao, Zhang Qingyuan, Teng Yuee, Cui Jiuwei, Wang Haibo, Yin Yongmei, Wang Xiaojia, Zhou Xin, Wang Yongsheng, Sun Gang, Wang Jingfen, Zhang Lili, Yang Jin, Qian Jun, Yan Min, Liu Xinlan, Yi Tienan, Cheng Ying, Li Man, Zang Aimin, Wang Shusen, Wang Chuan, Wu Xinhong, Cheng Jing, Li Hui, Lin Ying, Geng Cuizhi, Gu Kangsheng, Xie Chunwei, Xiong Huihua, Wu Xiaohong, Yang Junlan, Li Qingshan, Chen Yiding, Li Fanfan, Zhang Anqin, Zhang Yongqiang, Wu Yudong, Nie Jianyun, Liu Qiang, Wang Kun, Mo Xueli, Chen Lilin, Pan Yueyin, Fu Peifen, Zhang Helong, Pang Danmei, Sheng Yuan, Han Yunwei, Wang Hongxia, Cang Shundong, Luo Xianming, Yu Wenbo, Deng Rong, Yang Chaoqiang, Keegan Patricia
机构信息
Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Breast Internal Medicine Department, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
出版信息
Future Oncol. 2025 Feb;21(4):421-429. doi: 10.1080/14796694.2024.2430106. Epub 2024 Dec 4.
Zotero 插件